A 26-year-old Australian entrepreneur, once celebrated for his plant-based food startup, now faces serious charges after an intense confrontation with his ex-partner in a luxury New York hotel. The incident, which took place in late March, has drawn attention not just for the alleged violence but al
Back in 2009, a small group of experts started giving free, no-nonsense feedback to anyone trying to turn a muscle-disease idea into a real treatment. Their main job was to stop bad drugs from reaching patients too early, and to make sure good drugs had a fair shot at proving they worked. Over 15 ye
A high-fat, low-carb diet called keto has been around for decades. Doctors first used it to help control seizures in people with epilepsy. Now it’s everywhere—people eat it for weight loss or energy, not just for health problems. But what happens when pregnant women try this diet? That part is still
The White House plans to reveal a new deal with Regeneron Pharmaceuticals on pricing for their drugs. This move comes after the company was one of the few chosen to negotiate. Regeneron, which makes treatments like the Covid-19 antibody combo, didn’t comment right away. Their stock price jumped ove
Europe aims to cut down on forever chemicals, but one big exception could ruin the plan. PFAS are man-made compounds that never break down. They linger in water, soil, and even our bodies. The EU wants to limit their spread, yet factories can still pump out endless amounts under current rules. The
At 85, most people are winding down, but one entrepreneur is charging full steam ahead without a salary. His goal? Making healthcare cheaper, faster, and easier to access for everyone. Back in 2006, he cofounded a company that let migrant workers video-call their families and send money at the same
A young founder recently launched a yerba mate brand called Sollos, mixing the South American drink with tropical flavors like coconut and pineapple. The cans are bright and eye-catching, designed to stand out on shelves. But something feels off to many people. Sollos isn’t just another trendy drink
A fresh wave of support is rolling into Kyiv as the European Union signs off on a $106 billion loan after Hungary removed its long‑held veto. The money will largely go into Ukraine’s defense industry, a priority for both Kyiv and European security planners. The pause had started in December wh
Alzheimer’s isn’t just about memory loss—it’s a slow shutdown of the brain’s wiring. For years, scientists have tried to fix this by sending treatments directly to the brain, but the organ’s defenses make it nearly impossible. The tricky part? Most drugs can’t cross the brain’s protective barrier, w
Kevin O’Leary has trimmed his crypto list to just two tokens, saying the rest are not worth keeping. He used to spread his money across many small coins, but changes in rules and deeper studies by big investors made him rethink that plan. O’Leary argues that most of those smaller coins have lo
